10-KPeriod: FY2003

AGILENT TECHNOLOGIES, INC. Annual Report, Year Ended Oct 31, 2003

Filed December 22, 2003For Securities:A

Summary

Agilent Technologies, Inc. reported a challenging fiscal year ended October 31, 2003, marked by a significant net loss of $2.06 billion. This loss was heavily influenced by a $1.4 billion tax valuation allowance charge related to net deferred tax assets, as well as substantial restructuring and asset impairment charges totaling $372 million across its various plans aimed at reducing costs and returning the company to profitability. Despite the overall loss, the company saw signs of an upturn in its end markets, particularly in the fourth quarter, with orders reaching their highest level since Q1 2001. The company continued to manage its expenses diligently, reducing its workforce by approximately 15,000 employees since April 2001 and consolidating facilities to improve operational efficiency. The company's performance varied across its segments. The Test and Measurement segment experienced a revenue decline, reflecting the continued weakness in telecommunications markets. The Semiconductor Products segment showed some growth, driven by demand in personal systems and networking markets, although it faced pricing pressures. The Automated Test segment demonstrated improvement, returning to profitability in the latter half of the year, supported by growth in semiconductor test markets. The Life Sciences and Chemical Analysis segment reported revenue growth, bolstered by Asian economic development and new product introductions. Looking ahead, Agilent aims to sustain profitability by maintaining its reduced cost structure and leveraging an expected gradual economic recovery. The company's liquidity remained strong with significant cash and cash equivalents, though its credit ratings were downgraded to speculative grade by major agencies, impacting future borrowing costs.

Key Highlights

  • 1Agilent Technologies reported a net loss of $2.06 billion for the fiscal year ended October 31, 2003.
  • 2A significant factor in the net loss was a $1.4 billion charge for a tax valuation allowance.
  • 3Restructuring and asset impairment charges totaled $372 million, part of ongoing efforts to reduce costs and improve profitability.
  • 4The company saw encouraging signs of market recovery, with fourth-quarter orders reaching their highest level since the first quarter of 2001.
  • 5Headcount was reduced by approximately 15,000 employees since April 2001 as part of cost-cutting measures.
  • 6Performance varied by segment, with Life Sciences and Chemical Analysis showing revenue growth, while Test and Measurement faced continued market weakness.
  • 7Liquidity remained strong with $1.61 billion in cash and cash equivalents, despite credit rating downgrades to speculative grade.

Frequently Asked Questions

Agilent Technologies reported a substantial net loss of $2.06 billion for the fiscal year ended October 31, 2003. This was primarily due to a $1.4 billion tax valuation allowance charge and significant restructuring and asset impairment costs totaling $372 million. Despite these factors, the company observed a positive trend in orders, reaching the highest level in nearly two years by the fourth quarter, indicating potential market recovery.

The company undertook significant restructuring efforts, including workforce reductions and facility consolidations, to reduce costs and improve profitability. These efforts resulted in $372 million in restructuring and asset impairment charges during fiscal year 2003. While these charges contributed to the net loss, they also led to an annualized operating cost reduction of approximately $1.45 billion, with the company aiming to maintain this leaner cost structure going forward.

The Life Sciences and Chemical Analysis segment demonstrated positive revenue growth, driven by Asian economic development and new product introductions. The Automated Test segment showed signs of recovery, returning to profitability in the second half of the year. Conversely, the Test and Measurement segment experienced a revenue decline due to continued weakness in the telecommunications markets. The Semiconductor Products segment saw modest growth but faced pricing pressures common in the industry.

Agilent expressed cautious optimism for fiscal year 2004, anticipating a gradual economic recovery to benefit its various segments. The company's liquidity position remained strong, with $1.61 billion in cash and cash equivalents. However, it acknowledged credit rating downgrades to speculative grade by Standard & Poor's and Moody's, which could impact future borrowing costs. Agilent's strategic focus remains on maintaining its reduced cost structure and leveraging new product introductions for growth.